Abstract：
BACKGROUND: Patient-reported outcome measures (PROMs) are validated and standardized tools that complement physician evaluations and guide treatment decisions. They are crucial for monitoring atopic dermatitis (AD) and chronic urticaria (CU) in clinical practice, but there are unmet needs and knowledge gaps regarding their use in clinical practice.
UNASSIGNED: We investigated the global real-world use of AD and CU PROMs in allergology and dermatology clinics as well as their associated local and regional networks.
METHODS: Across 72 specialized allergy and dermatology centers and their local and regional networks, 2,534 physicians in 73 countries completed a 53-item questionnaire on the use of PROMs for AD and CU.
RESULTS: Of 2,534 physicians, 1,308 were aware of PROMs. Of these, 14% and 15% used PROMs for AD and CU, respectively. Half of physicians who use PROMs do so only rarely or sometimes. Use of AD and CU PROM is associated with being female, younger, and a dermatologist. The Patient-Oriented Scoring Atopic Dermatitis Index and Urticaria Activity Score were the most common PROMs for AD and CU, respectively. Monitoring disease control and activity are the main drivers of the use of PROMs. Time constraints were the primary obstacle to using PROMs, followed by the impression that patients dislike PROMs. Users of AD and CU PROM would like training in selecting the proper PROM.
CONCLUSIONS: Although PROMs offer several benefits, their use in routine practice is suboptimal, and physicians perceive barriers to their use. It is essential to attain higher levels of PROM implementation in accordance with national and international standards.
UNASSIGNED: We investigated the global real-world use of AD and CU PROMs in allergology and dermatology clinics as well as their associated local and regional networks.
METHODS: Across 72 specialized allergy and dermatology centers and their local and regional networks, 2,534 physicians in 73 countries completed a 53-item questionnaire on the use of PROMs for AD and CU.
RESULTS: Of 2,534 physicians, 1,308 were aware of PROMs. Of these, 14% and 15% used PROMs for AD and CU, respectively. Half of physicians who use PROMs do so only rarely or sometimes. Use of AD and CU PROM is associated with being female, younger, and a dermatologist. The Patient-Oriented Scoring Atopic Dermatitis Index and Urticaria Activity Score were the most common PROMs for AD and CU, respectively. Monitoring disease control and activity are the main drivers of the use of PROMs. Time constraints were the primary obstacle to using PROMs, followed by the impression that patients dislike PROMs. Users of AD and CU PROM would like training in selecting the proper PROM.
CONCLUSIONS: Although PROMs offer several benefits, their use in routine practice is suboptimal, and physicians perceive barriers to their use. It is essential to attain higher levels of PROM implementation in accordance with national and international standards.
摘要：
背景：患者报告的结果指标（PROMs）是经过验证和标准化的工具，可补充医师评估并指导治疗决策。在临床实践中，PROM对于监测特应性皮炎（AD）和慢性荨麻疹（CU）至关重要。但是在临床实践中使用它们存在未满足的需求和知识空白。
目的：我们调查了AD和CUPROM在变态反应学和皮肤病学诊所及其相关的本地和区域网络中的全球实际使用情况。
方法：在72个专门的过敏和皮肤科中心及其本地和区域网络中，73个国家/地区的2,534名医生完成了关于AD和CU使用PROM的53项问卷。
结果：在2,534名医生中，1,308人知道PROM。其中，14%和15%使用了AD和CU的PROM，分别。一半使用PROM的医生只“很少”或“有时”这样做。AD和CUPROM的使用与女性相关，年轻,和皮肤科医生.POSCORAD和UAS是AD和CU使用最多的PROM，分别。监测疾病控制和活动是使用PROM的主要驱动因素。时间限制是使用PROM的主要障碍。其次是患者不喜欢PROM的印象。AD和CUPROM用户希望接受选择适当PROM的培训。
结论：即使PROM提供了一些好处，它们在日常实践中的使用并不理想，和医生认为他们的使用障碍。必须根据国家和国际标准实现更高水平的PROM。
目的：我们调查了AD和CUPROM在变态反应学和皮肤病学诊所及其相关的本地和区域网络中的全球实际使用情况。
方法：在72个专门的过敏和皮肤科中心及其本地和区域网络中，73个国家/地区的2,534名医生完成了关于AD和CU使用PROM的53项问卷。
结果：在2,534名医生中，1,308人知道PROM。其中，14%和15%使用了AD和CU的PROM，分别。一半使用PROM的医生只“很少”或“有时”这样做。AD和CUPROM的使用与女性相关，年轻,和皮肤科医生.POSCORAD和UAS是AD和CU使用最多的PROM，分别。监测疾病控制和活动是使用PROM的主要驱动因素。时间限制是使用PROM的主要障碍。其次是患者不喜欢PROM的印象。AD和CUPROM用户希望接受选择适当PROM的培训。
结论：即使PROM提供了一些好处，它们在日常实践中的使用并不理想，和医生认为他们的使用障碍。必须根据国家和国际标准实现更高水平的PROM。
